Centro Hospitalar de São João

Porto 4200-319

0 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type 2, Drug Resistant Epilepsy, Epilepsy, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Obesity, Overweight, Seizures

Studies at this site

• A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes — Running, not enrolling
• Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early